Skip to content
Trial Eligibility
Menu

Lupus Clinical Trials near New York, NY

30 studies for Lupus are recruiting at 56 sites within 50 miles of New York, New York, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Lupus trials in the US or all trials near New York.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Lupus studies enrolling near New York

Showing 30 studies, nearest first.
  1. Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

    NCT05799378

    • Phase 3
    • Ages 55 years and older
    • Sex: All

    Nearest sites: Columbia University Irving Medical Center/New York Presbyterian (New York, NY); Hospital for Special Surgery (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  2. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    NCT03816345

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Laura and Isaac Perlmutter Cancer Center at NYU Langone (New York, NY); NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  3. An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

    NCT05835310

    • Phase 3
    • Ages 5 to 17 years
    • Sex: All

    Nearest sites: Research Site (New York, NY); Research Site (The Bronx, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  4. The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

    NCT05538208

    • Phase 2
    • Ages 8 to 20 years
    • Sex: All

    Nearest sites: Children's Hospital at Montefiore (New York, NY); Hospital for Special Surgery (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  5. A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

    NCT06557265

    • Phase 1/2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Nkarta Investigational Site (New York, NY); Nkarta Investigational Site (Summit, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  6. A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

    NCT06617325

    • Phase 3
    • Ages 16 years and older
    • Sex: All

    Nearest sites: Sl0044 50077 (New York, NY); Sl0044 50010 (Brooklyn, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  7. Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

    NCT00198068

    • Observational
    • Ages 18 to 45 years
    • Sex: Female
    • Accepts healthy volunteers

    Nearest sites: Hospital for Special Surgery (New York, NY); NYU Langone Medical Center/Hospital for Joint Diseases (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. VIBRANT: VIB4920 for Active Lupus Nephritis

    NCT05201469

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Columbia University Medical Center: Department of Medicine, Division of Rheumatology (New York, NY); Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases (Manhasset, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  9. Lupus Landmark Study: A Prospective Registry and Biorepository

    NCT05934149

    • Observational
    • Ages 18 to 110 years
    • Sex: All

    Nearest sites: Northwell Health (New York, NY); The Feinstein Institutes for Medical Research (Manhasset, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  10. A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

    NCT06570798

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Columbia University Medical Center (New York, NY); Northwell Health (Great Neck, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  11. A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

    NCT07085104

    • Phase 1
    • Ages 18 to 74 years
    • Sex: All

    Nearest sites: Icahn School of Medicine at Mount Sinai (New York, NY); Astera Cancer Care (East Brunswick, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

    NCT01802034

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: The Rogosin Institute (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. Safety of the Herpes Zoster Subunit Vaccine in Lupus

    NCT05559671

    • Phase 4
    • Ages 18 to 90 years
    • Sex: All

    Nearest site: NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

    NCT06308978

    • Phase 1
    • Ages 12 to 70 years
    • Sex: All

    Nearest site: Montefiore Medical Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

    NCT06613360

    • Phase 1
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Columbia University Medical Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

    NCT06875960

    • Phase 4
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: New York University School Of Medicine (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

    NCT06897930

    • Phase 1/2
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Research Site (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

    NCT07053800

    • Phase 2
    • Ages 12 to 65 years
    • Sex: All

    Nearest site: Icahn School of Medicine at Mount Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Safety and Efficacy of ONT01 in Lupus

    NCT07107659

    • Early Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Hospital for Special Surgery (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

    NCT07138898

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Alnuctamab for Refractory SLE (LATTE Study)

    NCT07219563

    • Phase 1
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: Icahn School of Medicine at Mount Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. HEALTH Home Urinalysis Testing

    NCT07823478

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

    NCT07175285

    • Observational
    • Ages 16 years and older
    • Sex: All

    Nearest sites: Kings County Hospital Center - Brooklyn (Brooklyn, NY); Sahni Rheumatology & Therapy (West Long Branch, NJ)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  24. A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

    NCT07438496

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Rutgers New Jersey Medical School (Newark, NJ); Arthritis Rheumatic And Back Disease Associates (Voorhees Township, NJ)

    Distance to nearest recruiting site
    ~9 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  25. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

    NCT05039619

    • Phase 2
    • Ages 5 to 17 years
    • Sex: All

    Nearest sites: Cohen Children's Medical Center of New York (Queens, NY); Hackensack University Medical Center (Hackensack, NJ)

    Distance to nearest recruiting site
    ~9 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  26. Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus

    NCT06232304

    • Interventional
    • Ages 12 to 22 years
    • Sex: All

    Nearest site: Montefiore Medical Center (The Bronx, NY)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

    NCT07328581

    • Phase 2
    • Ages 16 to 70 years
    • Sex: All

    Nearest site: NorthWell (New Hyde Park, NY)

    Distance to nearest recruiting site
    ~17 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. Trial of Belimumab in Early Lupus

    NCT03543839

    • Phase 4
    • Ages 18 years and older
    • Sex: All

    Nearest site: Feinstein Institute (Manhasset, NY)

    Distance to nearest recruiting site
    ~17 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. Transcutaneous Vagus Nerve Stimulation in SLE

    NCT06987565

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Feinstein Institutes for Medical Research (Manhasset, NY)

    Distance to nearest recruiting site
    ~17 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

    NCT07611214

    • Phase 4
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Sahni Rheumatology & Therapy (West Long Branch, NJ)

    Distance to nearest recruiting site
    ~29 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Lupus clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.